Dr. Cottrell completed her Doctor of Pharmacy, Master of Pharmaceutical Sciences and a general practice pharmacy residency at the University of Oklahoma. To advance her formal training in antiretroviral pharmacology, she completed an ACCP accredited HIV pharmacology fellowship followed by an ABCP accredited T32 clinical pharmacology fellowship, both at the UNC Eshelman School of Pharmacy. She joined the faculty there in 2015 within the Division of Pharmacotherapy and Experimental Therapeutics and serves as the Co-Director for the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core. She is a Board-Certified Pharmacotherapy Specialist and an American Academy of HIV Medicine-HIV PharmacistTM. Her research focuses on characterizing PK/PD relationships for antiretrovirals and latency reversing agents and utilizing in vitro and mathematical modeling techniques to identify HIV treatment and cure strategies that are tailored for specific end user populations. Additionally, she is the principle investigator on an NIH funded research program to characterize HIV PrEP pharmacology within transmission sites in transgender women taking feminizing hormone therapy.
